REAL-WORLD EFFECTIVENESS OF ECULIZUMAB, SWITCH TO RAVULIZUMAB AND RAVULIZUMAB AS FIRST THERAPY IN SWISS PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

被引：0
|
作者：
Rovo, A. [1 ,2 ]
Simeon, L. [3 ]
Gavillet, M. [4 ,5 ,6 ]
Samii, K. [7 ]
Cantoni, N. [8 ]
Drexler, B. [9 ]
Stussi, G. [10 ]
Bissig, M. [11 ]
机构：
[1] Univ Hosp Bern, Dept Hematol, Inselspital, Bern, Switzerland
[2] Univ Hosp Bern, Cent Hematol Lab, Inselspital, Bern, Switzerland
[3] Cantonal Hosp Lucerne, Dept Hematol, Luzern, Switzerland
[4] Lausanne Univ Hosp CHUV, Dept Oncol, Serv & Cent Lab Hematol, Lausanne, Switzerland
[5] Lausanne Univ Hosp CHUV, Dept Lab Med & Pathol, Lausanne, Switzerland
[6] Ctr Lausannes Epalinges, Interreg Blood Tranfus SRC, Epalinges, Switzerland
[7] Geneva Univ Hosp, Div Hematol, Dept Oncol, Geneva, Switzerland
[8] Cantonal Hosp Aarau, Div Oncol Hematol & Tranfus Med, Aarau, Switzerland
[9] Univ Hosp Basel, Dept Hematol, Basel, Switzerland
[10] Oncol Inst Southern Switzerland, Clin Hematol, Bellinzona, Switzerland
[11] Univ Hosp Zurich, Dept Med Oncol & Hematol, Zurich, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2023年 / 153卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
225
引用
收藏
页码：30S / 31S
页数：2
相关论文
共 50 条
  • [11] 20 years' experience of eculizumab and ravulizumab therapy in 509 patients with paroxysmal nocturnal haemoglobinuria
    Holt, Matthew
    Kelly, Richard J.
    Vidler, Jennifer
    Arnold, Louise
    Large, Joanna
    Forrest, Briony
    Barnfield, Catherine
    Pike, Alexandra
    Griffin, Morag
    Munir, Talha
    Muus, Petra
    Nagumantry, Sateesh
    Trikha, Roochi
    Kulasekararaj, Austin
    Mitchell, Lindsay
    Gandhi, Shreyans
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 22 - 22
  • [12] COMPARISON OF LOST PRODUCTIVITY DUE TO ECULIZUMAB AND RAVULIZUMAB TREATMENTS FOR PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN THE UNITED STATES
    Levy, A. R.
    Tomazos, I
    Patel, Y.
    Donato, B. M. K.
    Briggs, A.
    [J]. VALUE IN HEALTH, 2019, 22 : S377 - S377
  • [13] Switching From High-Dose Eculizumab to Ravulizumab in Paroxysmal Nocturnal Hemoglobinuria: A Case Report
    Fuereder, Wolfgang
    [J]. HEMASPHERE, 2020, 4 (04):
  • [14] Breakthrough Haemolysis Rates Among Patients With Paroxysmal Nocturnal Haemoglobinuria Who Switched From Eculizumab to Ravulizumab Treatment: A Real-World Analysis
    Fishman, Jesse
    Kuranz, Seth
    Yeh, Michael
    Brzozowski, Kaylen
    Chen, Herman
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 : 139 - 140
  • [15] Descriptive, real-world treatment patterns, resource use, and total cost of care among eculizumab- and ravulizumab-treated members with paroxysmal nocturnal hemoglobinuria
    Broderick, Kelly C.
    Burke, James P.
    Fishman, Jesse
    Gleason, Patrick P.
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2023, 29 (08): : 941 - 951
  • [16] Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparison
    Bhak, Rachel H.
    Mody-Patel, Nikita
    Baver, Scott B.
    Kunzweiler, Colin
    Yee, Christopher W.
    Sundaresan, Sanjana
    Swartz, Natalia
    Duh, Mei Sheng
    Krishnan, Sangeeta
    Sarda, Sujata P.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (11) : 1913 - 1923
  • [17] Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparison
    Bhak, Rachel
    Mody-Patel, Nikita
    Baver, Scott B.
    Kunzweiler, Colin
    Yee, Christopher
    Sundaresan, Sanjana
    Swartz, Natalia
    Duh, Mei Sheng
    Krishnan, Sangeeta
    Sarda, Sujata P.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 190 - 190
  • [18] Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria Previously Treated with Eculizumab: A Matching-Adjusted Indirect Comparison
    Bhak, Rachel Y.
    Mody-Patel, Nikita
    Baver, Scott B.
    Kunzweiler, Colin
    Yee, Christopher
    Sundaresan, Sanjana
    Swartz, Natalia
    Duh, Mei Sheng
    Krishnan, Sangeeta
    Sarda, Sujata P.
    [J]. BLOOD, 2020, 136
  • [19] Real-World Efficacy of Eculizumab for Paroxysmal Nocturnal Hemoglobinuria in South Korea: Paradox of Eculizumab
    Kang, Ka-Won
    Moon, Hyemi
    Lee, Byung-Hyun
    Jeon, Min Ji
    Yu, Eun Sang
    Kim, Dae Sik
    Lee, Se Ryeon
    Sung, Hwa Jung
    Kim, Seok Jin
    Choi, Chul Won
    Kim, Byung Soo
    Lee, Juneyoung
    Park, Yong
    [J]. BLOOD, 2019, 134
  • [20] Norm-based comparison of the quality-of-life impact of ravulizumab and eculizumab in paroxysmal nocturnal hemoglobinuria
    Carolyn E. Schwartz
    Roland B. Stark
    Katrina Borowiec
    Sandra Nolte
    Karl-Johan Myren
    [J]. Orphanet Journal of Rare Diseases, 16
12345